National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 9073-9074 [2022-03386]
Download as PDF
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Notices
Review, The National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD 20892,
301–496–9295, zarana.shavers@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 14, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Center for Scientific
Review Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. URL for
virtual access: https://videocast.nih.gov/
watch=44677.
Name of Committee: Center for Scientific
Review Advisory Council.
Date: March 28, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bruce Reed, Ph.D., Deputy
Director, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594–9159,
reedbr@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
public.csr.nih.gov/AboutCSR/Organization/
CSRAdvisoryCouncil, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
17:23 Feb 16, 2022
Jkt 256001
Dated: February 14, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–03438 Filed 2–16–22; 8:45 am]
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
[FR Doc. 2022–03455 Filed 2–16–22; 8:45 am]
9073
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel:
Conflicting F and K Grant Applications of
NRRC.
Date: March 4, 2022.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, 6701 Democracy Boulevard
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Immunology
(IMM), DPPS, Center for Scientific Review,
National Institute of Nursing Research,
National Institutes of Health, 6701 Rockledge
Drive, Room 4205, Bethesda, MD 20892, 301–
594–0343, yanming@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: February 14, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03439 Filed 2–16–22; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: P30 Core
Centers for Clinical Research Meeting.
Date: March 2–3, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838, mak2@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
Mechanistic Ancillary Studies Review
Meeting.
Date: March 11, 2022.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 820, Bethesda,
MD 20892, 301–827–7835,
yasuko.furumoto@nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
AMS Member Conflict Review.Date: March
11, 2022.
E:\FR\FM\17FEN1.SGM
17FEN1
9074
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Notices
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marisol Espinoza-Pintucci,
Ph.D., Scientific Reviewer Officer, Scientific
Review Branch, National Institute of
Arthritis, Musculoskeletal and Skin Diseases,
6701 Democracy Boulevard, Suite 816,
Bethesda, MD 20892, 301–827–6959,
Marisol.espinoza-pintucci@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: February 11, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03386 Filed 2–16–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Member Conflict SEP.
Date: February 21, 2022.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, National
Institutes of Health, National Institute of
Neurological Disorders and Stroke, 6001
Executive Boulevard, Suite 3208, Rockville,
MD 20852, 301–496–3755,
natalia.strunnikova@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
VerDate Sep<11>2014
17:23 Feb 16, 2022
Jkt 256001
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: February 14, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03440 Filed 2–16–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Frederick National
Laboratory Advisory Committee to the
National Cancer Institute, February 24,
2022, 1:00 p.m. to February 24, 2022,
4:30 p.m., National Cancer Institute
Shady Grove, 9609 Medical Center
Drive, Rockville, MD 20850 which was
published in the Federal Register on
February 4, 2022, FR Doc 2022–02367,
87 FR 6617.
This notice is being amended to
change the meeting end time from 4:30
p.m. to 4:00 p.m. The meeting will now
be held from 1:00 p.m. to 4:00 p.m. The
meeting is open to the public.
Dated: February 14, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03433 Filed 2–16–22; 8:45 am]
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel: Mechanism for TimeSensitive Research Opportunities in
Environmental Health Sciences (R21).
Date: March 4, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Science, 530 Davis Drive, Keystone
Building, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Varsha Shukla, Ph.D.,
Scientific Review Branch, Division of
Extramural Research and Training, National
Institute of Environmental Health Science,
530 Davis Drive, Keystone Building, Room
3094, Durham, NC 27713, 984–287–3288,
Varsha.shukla@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: February 11, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03381 Filed 2–16–22; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\17FEN1.SGM
17FEN1
Agencies
[Federal Register Volume 87, Number 33 (Thursday, February 17, 2022)]
[Notices]
[Pages 9073-9074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03386]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: P30 Core
Centers for Clinical Research Meeting.
Date: March 2-3, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, 6701 Democracy Boulevard, Bethesda, MD 20817 (Virtual
Meeting).
Contact Person: Kan Ma, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard,
Suite 814, Bethesda, MD 20892, 301-451-4838, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: NIAMS
Mechanistic Ancillary Studies Review Meeting.
Date: March 11, 2022.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
820, Bethesda, MD 20892, 301-827-7835, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: NIAMS AMS
Member Conflict Review.Date: March 11, 2022.
[[Page 9074]]
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Marisol Espinoza-Pintucci, Ph.D., Scientific
Reviewer Officer, Scientific Review Branch, National Institute of
Arthritis, Musculoskeletal and Skin Diseases, 6701 Democracy
Boulevard, Suite 816, Bethesda, MD 20892, 301-827-6959,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: February 11, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03386 Filed 2-16-22; 8:45 am]
BILLING CODE 4140-01-P